Panther system reagents. Base period 2/1/2022 to 9/30/2022

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0222D0003
Awardee
Awarding agency
Task orders
7 $2,320,936 obligated

Award facts

Opportunity
Combined order value
$2,895,531 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 42% used
$5,559,883.00
Maximum order
$5,273,433.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

Hologic Sales and Service, LLC, a subsidiary of Hologic, Inc., was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on February 1, 2022, with a ceiling value of $5.56 million and an ultimate completion date of September 30, 2024. The contract was awarded without set-aside designation through full and open competition and establishes a procurement vehicle for Panther System reagents during the base period (February 1, 2022 to September 30, 2022) and subsequent option periods, with the option period II increasing quantities on contract line item numbers 2004, 2006, 2007, and 2008. Panther reagents are consumable supplies used in Hologic's Panther molecular diagnostic systems, which support in-vitro diagnostic testing capabilities essential to clinical laboratory operations within the Defense Health Agency's healthcare infrastructure. The contract encompasses both domestic performance (Marlborough, Massachusetts) and international performance (South Korea), reflecting the geographic distribution of military and defense healthcare facilities requiring these diagnostic reagents.

Six delivery orders issued under this contract vehicle demonstrate sustained procurement demand, with cumulative values exceeding $2.77 million across the contract period. Delivery orders were issued to support operations at Defense Health Agency facilities, the Army Medical Command, and the Brian D. Allgood Army Community Hospital in South Korea, with performance periods ranging from February through September 2022 and extending through September 2024. The delivery orders were structured as firm fixed-price contracts, with values ranging from $4,600 to $1.13 million, and all were awarded without set-aside designations. Earlier delivery orders (February through September 2022) were issued under Gen-Probe nomenclature at Marlborough, Massachusetts addresses, reflecting organizational naming conventions and transitions. The subsequent delivery orders (June 2023 through July 2024) were issued to Hologic Sales and Service, LLC with performance in South Korea, indicating the contract's evolution to support specific geographic military healthcare requirements throughout the contract period.

Task orders

Task order Ordering agency Obligated Awarded
Hologic panther reagents option period 2, 3RD delivery order: 7/15/24 to 9/30/24. W81K0224F0100 Medical Command (Army) $26,400
Hologic panther reagents option period 2, 2ND delivery order: 5/1/24 to 9/30/24 W81K0224F0052 Medical Command (Army) $166,560
Hologic panther reagents option period 2, delivery order: 10/1/2023 to 9/30/2024 W81K0223F0129 Medical Command (Army) $0
Panther reagents do for POP: 6/1/2023 to 9/30/2023 W81K0223F0061 Medical Command (Army) $4,600
Panther reagents do for POP: 10/1/2022 to 9/30/2023 W81K0222F0082 Medical Command (Army) $700,250
Panther reagents do#2 POP: 4/29/2022 to 9/30/2022 W81K0222F0064 Medical Command (Army) $1,134,490
Panther system reagents do #1 W81K0222F0034 Medical Command (Army) $288,636

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Panther reagents for bdaach option period II : increase quantities on clins 2004, 2006, 2007, 2008 $0
Exercise an Option P00008 · Hologic panther reagents, exercise option period II: 10/1/2023 to 9/30/2024 $0
Supplemental Agreement for work within scope P00007 · Option period 2: increase quantities on clins 2004, 2007,2008 and 2020 $0
Supplemental Agreement for work within scope P00006 · Panther system reagents - add 52.204-27 prohibition on bytedance covered application $0
Novation Agreement P00005 · Reagents, modification to restructure clins with UOM job or lot $0
Other Administrative Action P00004 · Option period 1: 10/1/2022 to 9/30/2023 modification to correct ordering end date. $0
Supplemental Agreement for work within scope P00003 · Reagents & consummables for panther system, update item list $0
Supplemental Agreement for work within scope P00002 · Reagent & consumables for panther system (korea), update item LIT, option 1 - 10/1/2022 to 9/30/2023 $0
Exercise an Option P00001 · Hologic panther reagents exercise option period 1: 10/1/2022 to 9/30/2023 $0
Original award $0

Quick answers

Who was awarded contract W81K0222D0003?

W81K0222D0003 was awarded to Hologic Sales And Service, LLC by Medical Command (Department of the Army) on February 1, 2022.

How much is contract W81K0222D0003 worth?

Orders under W81K0222D0003 have obligated $2,320,936. Their combined current value, with exercised options, is $2,895,531. W81K0222D0003's own ceiling is $5,559,883. A single order can be worth up to $5,273,433.

How many orders have been placed under contract W81K0222D0003?

7 orders have been placed under W81K0222D0003, the latest on July 15, 2024.

Which agency awarded contract W81K0222D0003?

Medical Command (Department of the Army) awarded W81K0222D0003, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0222D0003?

W81K0222D0003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0222D0003 competed?

The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login